What diagnosis should I use for prescribing Zofran (ondansetron) for a patient with motion sickness from a cruise?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Appropriate Diagnosis Code for Prescribing Ondansetron for Seasickness

For prescribing ondansetron (Zofran) for seasickness from a cruise, the most appropriate diagnosis code would be "Motion Sickness" (ICD-10 code T75.3) as ondansetron is not FDA-approved for this indication and is not recommended as first-line therapy for motion sickness.

Understanding Motion Sickness and Treatment Options

  • Motion sickness is a common syndrome occurring upon exposure to certain types of motion, thought to be caused by conflict between the vestibular, visual, and other proprioceptive systems 1
  • Nausea is the hallmark symptom, often preceded by stomach awareness, malaise, drowsiness, and irritability 1
  • Air travel and sea travel can significantly affect individuals, causing symptoms ranging from mild discomfort to severe nausea and vomiting 2

Evidence Regarding Ondansetron for Motion Sickness

  • Ondansetron has not been shown to be effective in the prevention and treatment of motion sickness 1
  • Studies specifically evaluating ondansetron for seasickness found no statistically significant reduction of seasickness symptoms compared to placebo 3
  • Even high-dose ondansetron did not prevent motion sickness in highly susceptible individuals 4

First-Line Recommended Treatments for Motion Sickness

  • Scopolamine is considered first-line medication for prevention of motion sickness and should be administered transdermally several hours before anticipated motion exposure 1
  • First-generation antihistamines, although sedating, are also effective for motion sickness prevention 1, 5
  • Antihistamines are probably more effective than placebo at preventing motion sickness symptoms under natural conditions (RR 1.81,95% CI 1.23 to 2.66) 5

Behavioral Strategies for Motion Sickness

  • Patients should be counseled about positioning themselves in the most stable part of the vessel 1
  • Watching the true visual horizon and minimizing exposure to unpleasant motion can help reduce symptoms 1
  • Lying down with eyes closed may also provide relief 1

Cautions Regarding Off-Label Use

  • Using ondansetron for motion sickness represents off-label use, as it is primarily indicated for chemotherapy-induced nausea and vomiting, postoperative nausea and vomiting, and radiation-induced nausea and vomiting 2
  • When prescribing medications off-label, it's important to document the clinical rationale and that standard treatments have been considered or tried 6

Alternative Antiemetic Options with Better Evidence

  • Metoclopramide has been used for seasickness, but caution is warranted due to potential for serious adverse effects even with short-term, low-dose use 7
  • Prochlorperazine may be considered for short-term management of severe nausea or vomiting in patients who are severely symptomatic 6

Documentation Recommendations

  • When prescribing ondansetron off-label for seasickness, document:
    • The diagnosis of "Motion Sickness" (ICD-10 code T75.3)
    • That first-line therapies (scopolamine, first-generation antihistamines) were considered
    • Patient's preference for ondansetron despite limited evidence for this indication
    • Discussion of potential risks and benefits of off-label use

References

Research

Prevention and treatment of motion sickness.

American family physician, 2014

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

High dose ondansetron for reducing motion sickness in highly susceptible subjects.

Aviation, space, and environmental medicine, 2007

Research

Antihistamines for motion sickness.

The Cochrane database of systematic reviews, 2022

Guideline

Role of Prochlorperazine in Vertigo Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.